There was no significant difference in tumor weight between the gradient RMF treatment group and the gradient RMF treatment + si-CCDC150 group, and similar results were observed with H&E staining, Ki67, and liver function (Fig. S11A to H). This evidence concerns the gene CCDC150 and neoplasm.